1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Lumos Diagnostics Holdings Limited
  6. News
  7. Summary
    LDX   AU0000157091

LUMOS DIAGNOSTICS HOLDINGS LIMITED

(LDX)
  Report
Delayed Australian Stock Exchange  -  05/16 10:23:19 pm EDT
0.2800 AUD   -1.75%
04/10Lumos Diagnostics Holdings Limited Announces Appoints Rob Sambursky to the Role of Chief Medical Officer
CI
04/10Lumos Diagnostics Announces Appointment of Current Executive Chair Sam Lanyon as Interim CEO
CI
03/31LUMOS DIAGNOSTICS : Notification regarding unquoted securities - LDX
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Lumos Diagnostics Launches Respiratory Infection Test in Liverpool, UK

01/11/2022 | 09:52pm EDT


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
LUMOS DIAGNOSTICS HOLDINGS LIMITED -5.00% 0.28 Delayed Quote.-71.36%
ON SEMICONDUCTOR CORPORATION -1.83% 55.15 Delayed Quote.-18.80%
All news about LUMOS DIAGNOSTICS HOLDINGS LIMITED
04/10Lumos Diagnostics Holdings Limited Announces Appoints Rob Sambursky to the Role of Chie..
CI
04/10Lumos Diagnostics Announces Appointment of Current Executive Chair Sam Lanyon as Interi..
CI
03/31LUMOS DIAGNOSTICS : Notification regarding unquoted securities - LDX
PU
02/27LUMOS DIAGNOSTICS : FY2022 Half Year Update
PU
02/27Lumos Diagnostics Announces That It Received Market Authorization for the FebriDx« Test..
CI
02/27LUMOS DIAGNOSTICS : Appendix 4D and Half Year Report
PU
02/27Lumos Diagnostics Holdings Limited Reports Earnings Results for the Half Year Ended Dec..
CI
02/15Lumos Diagnostics Names New CFO; Shares Decline 6%
MT
02/15Lumos Diagnostics Announces Appointment of Barrie Lambert as Chief Financial Officer fo..
CI
02/10Lumos Diagnostics Holdings Limited Resignation Rob Sambursky from its Board
CI
More news
Financials
Sales 2022 20,5 M 14,2 M 14,2 M
Net income 2022 -19,1 M -13,2 M -13,2 M
Net cash 2022 30,8 M 21,3 M 21,3 M
P/E ratio 2022 -2,27x
Yield 2022 -
Capitalization 43,0 M 29,7 M 29,7 M
EV / Sales 2022 0,59x
EV / Sales 2023 0,56x
Nbr of Employees -
Free-Float 56,8%
Chart LUMOS DIAGNOSTICS HOLDINGS LIMITED
Duration : Period :
Lumos Diagnostics Holdings Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 0,29 AUD
Average target price 0,63 AUD
Spread / Average Target 119%
EPS Revisions
Managers and Directors
Sam Lanyon Executive Chairman & Chief Executive Officer
Barrie Lambert Chief Financial Officer
Robert P. Sambursky Chief Medical Officer
Sacha Dopheide Chief Technology Officer
Jeffrey Bishop SVP-Research & Development